| 28/10/2024 13:29 | duaesigned.pdf | Doc. de eligibilitate (DUAE) | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | duaesigned.pdf | Romana |
| 28/10/2024 13:29 | gb_tetis_capcs_24102024-185kmdlsignedsigned.pdf | Garanții | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | gb_tetis_capcs_24102024-185kmdlsignedsigned.pdf | Romana |
| 28/10/2024 17:24 | cereredeparticiparesigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | cereredeparticiparesigned.pdf | Romana |
| 28/10/2024 17:24 | certificatdeinregistraresigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | certificatdeinregistraresigned.pdf | Romana |
| 28/10/2024 17:24 | declaratieprivindvalabilitateaoferteisigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | declaratieprivindvalabilitateaoferteisigned.pdf | Romana |
| 28/10/2024 17:24 | declaratiesigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | declaratiesigned.pdf | Romana |
| 28/10/2024 17:24 | fondatorsigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | fondatorsigned.pdf | Romana |
| 28/10/2024 17:24 | licentasigned.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | licentasigned.pdf | Romana |
| 28/10/2024 17:24 | lipsarestantelor01112025signed.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | lipsarestantelor01112025signed.pdf | Romana |
| 28/10/2024 17:24 | propunereafinanciarasigned.pdf | Propunere financiară | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | propunereafinanciarasigned.pdf | Romana |
| 28/10/2024 17:24 | propunereatehnicasigned.pdf | Propunere tehnică | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | propunereatehnicasigned.pdf | Romana |
| 28/10/2024 17:24 | raportfinanciar2023signed.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | raportfinanciar2023signed.pdf | Romana |
| 28/10/2024 17:24 | extrastetis12072024signed.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | extrastetis12072024signed.pdf | Romana |
| 28/10/2024 17:24 | 4149_001signed.pdf | Doc. de calificare | Dolutegravirum + Lamivudinum + Tenofoviri disoproxili fumaras 50 mg/300 mg/300 mg | 4149_001signed.pdf | Romana |